10x Genomics Inc

Financials

営業活動によるキャッシュフロー -217.9 M-21.37 M-33.61 M-15.2 M6.66 M136.05 M 136.05 M 投資活動によるキャッシュフロー -38.39 M-106.73 M-350.89 M133.49 M-32.63 M-13.44 M -13.44 M 財務活動によるキャッシュフロー 468.91 M35.3 M15.82 M13.67 M10.91 M6.8 M 6.8 M フリーキャッシュフロー -256.29 M-122.65 M-165.27 M-64.72 M-6.73 M130.12 M 130.12 M

10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.

TXG

Financials

10x Genomics Inc

ニュース

Stock Picks From Seeking Alpha's March 2026 New Analysts

Canada stocks higher at close of trade; S&P/TSX Composite up 0.58%

Tempus AI Reinforces Market Position With Collaborations in 2026

10x Genomics: Undervalued Amid Consumables-Led Transition (NASDAQ:TXG)

Tempus AI's Diagnostics and Data Arms Drive Long-Term Growth Story

マイクロソフトのAI空間解析ツールへの懸念で10X Genomics株が下落

10X Genomics stock falls on Microsoft AI spatial tool concerns

Micron and Intel among market cap stock movers on Monday

ARK Investが株式を売却し10x Genomicsの株価が急落

10x Genomics stock tumbles as ARK Invest dumps shares

キャシー・ウッドのARK、CRISPR株を買い増し、10x Genomicsを売却

Cathie Wood’s ARK stock trades highlight CRISPR buys, 10x Genomics sells